In this investigation, we further deepen our understanding of TIME-based antitumor immune responses by exploring and understanding the role of MMR gene patterns in the immune landscape of lung adenocarcinoma and use this as a springboard to provide more effective LUAD patients. The gene discussed is MRC1; the disease is lung adenocarcinoma.